Clinical updates, including trial initiations, enrollment status and data readouts and publications: Bicycle, Bioxcel, Bristol Myers Squibb, Can-Fite, Engene, Exelixis, Ipsen, Kalvista, Macrogenics, Maia, Merck, Monopar, Nervgen, Propella, Puretech, Purple, Relief, Seres, Valneva, Vaxart.